Sitagliptin/metformin, sold under the brand name Januet among others, is an anti-diabetic drug, being a combination drug of sitagliptin (a dipeptidyl peptidase-4 inhibitor) and metformin. It is used a third-line treatment for people who do not achieve control of their blood sugar with metformin alone, or after trying to add sulfonylurea, pioglitazone, or insulin to the treatment. As of 2018 the combination was marketed under several brand names, including Efficib, Janmet, Januet, Janumet, Jznumet, Ristaben Met, Ristfor, Siglimet, Sitamet, Sitar-M, Sliptin-M, Treviamet, and Velmetia. This is not a list of all drugs or health problems that interact with this medicine (sitagliptin and metformin tablets). Tell your doctor and pharmacist about all of your drugs (prescription or OTC, natural products, vitamins) and health problems. You must check to make sure that it is safe for you to take this medicine (sitagliptin and metformin tablets) with all of your drugs and health problems. Do not start, stop, or change the dose of any drug without checking with your doctor. WARNING/CAUTION: Even though it may be rare, some people may have very bad and sometimes deadly side effects when taking a drug. Tell your doctor or get medical help right away if you have any of the following signs or symptoms that may be related to a very bad side effect: All drugs may cause side effects. However, many people have no side effects or only have minor side effects. Amoxil forte syrup Xanax statistics JANUMET is a powerful type 2 diabetes medicine that combines 2 prescription medicines, sitagliptin JANUVIA ® and metformin, and can lower blood sugar more than the most commonly prescribed medicine metformin. Diabetes Mellitus, Type 2. Adjust dose gradually considering effectiveness and tolerability Inadequately controlled on metformin alone 100 mg/day sitagliptin PO plus current dose of metformin Not to exceed daily PO dose of 2,000 mg of metformin or 100 mg or sitagliptin. DESCRIPTION. JANUMET XR tablets contain two oral antidiabetic medications used in the management of type 2 diabetes sitagliptin and metformin hydrochloride extended-release. Sitagliptin. Sitagliptin is an orally-active inhibitor of the dipeptidyl peptidase-4 DPP-4 enzyme. Sitagliptin phosphate monohydrate drug substance is used to manufacture JANUMET XR. This may be the result of a broken link, expired bookmark, or mistyped URL. Please consider using the search field or links below to navigate to the desired page on Metformin and sitagliptin are oral diabetes medicines that help control blood sugar levels. Metformin works by decreasing glucose (sugar) production in the liver and decreasing absorption of glucose by the intestines. Sitagliptin works by regulating the levels of insulin your body produces after eating. Metformin and sitagliptin is a combination medicine that is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. metformin and sitagliptin is not for treating type 1 diabetes. Metformin and sitagliptin may also be used for purposes not listed in this medication guide. You should not use this medicine if you have severe kidney disease or diabetic ketoacidosis (call your doctor for treatment). Metformin sitagliptin Sitagliptin und Sitagliptin/Metformin bei Typ-2., Janumet, Janjumet XR metformin-sitagliptin dosing. Azithromycin ppt Tablette enthält 50 mg Sitagliptin und 1.000 mg Metforminhydrochlorid. wenn Sie allergisch gegen Sitagliptin oder Metformin oder einen der in Abschnitt 6. Janumet® 50mg / 1000 mg Filmtabletten - PatientenInfo-Service. Janumet Sitagliptin Metformin HCL Side Effects.. Metformin and sitagliptin Uses, Side Effects & Warnings.. Febr. 2014. Auch dient die Kombination der Vereinfachung einer Therapie, die zunächst mit Metformin und Sitagliptin als Einzelwirkstoffen begonnen. Mai 2018. Allerdings machen einige Apotheker in letzter Zeit die Beobachtung, dass Typ-2- Diabetiker, die Sitagliptin und Metformin erhalten, von der. Sitagliptin/Metformin Janumet as Combination Therapy In the Treatment of Type-2 Diabetes Mellitus. Erin L. St. Onge, PharmD. Of the 25.8 million Americans with type-2 diabetes mellitus, 7 million of these individuals are unaware that they have the disease.